For diabetes treatment, nine (6%) patients were prescribed diet and exercise only, 95 (62%) were taking oral hypoglycemic agents alone, 35 (23%) were taking insulin, and 22 (15%) were taking glucagon-like peptide-1 receptor agonists. This evidence concerns the gene GLP1R and diabetes mellitus.